Miller-Fisher syndrome after first dose of Oxford/AstraZeneca coronavirus disease 2019 vaccine: a case report

Review Medicine, General & Internal

Miller Fisher syndrome after COVID-19 vaccination: Case report and review of literature

Ahsun Rizwan Siddiqi et al.

Summary: This case report describes a rare case of Miller Fisher syndrome (MFS) occurring after COVID-19 vaccination and highlights the need for further research to establish a temporal association.

MEDICINE (2022)

添加到收藏夹

Review Clinical Neurology

Guillain-Barre syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases

Samir Abu-Rumeileh et al.

Summary: This study systematically reviewed 73 cases of GBS associated with COVID-19 reported in publications until July 2020. Most patients developed GBS manifestations after COVID-19 infection, with a majority showing good prognosis, and a male predominance was observed.

JOURNAL OF NEUROLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Case of Guillain-Barre syndrome following COVID-19 vaccine

Tanveer Hasan et al.

Summary: This case report presents a instance of Guillain-Barre syndrome occurring after receiving the Oxford/AstraZeneca COVID-19 vaccine. While a direct link could not be established, it emphasizes the need to consider this issue when evaluating cases of GBS.

BMJ CASE REPORTS (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Looking beyond COVID-19 vaccine phase 3 trials

Jerome H. Kim et al.

Summary: Following the announcement of COVID-19 vaccine efficacy in clinical trials, a comprehensive strategy is needed for global vaccination, including manufacturing, support, supply coordination, equitable distribution, and logistics. Additionally, addressing scientific questions to improve vaccine efficacy is crucial for ending the pandemic effectively and efficiently.

NATURE MEDICINE (2021)

添加到收藏夹

Article Clinical Neurology

Cerebrospinal fluid analysis in Guillain-Barre syndrome: value of albumin quotients

Jakob Rath et al.

Summary: Albuminocytologic dissociation in cerebrospinal fluid (CSF) is a diagnostic hallmark of Guillain-Barre syndrome (GBS). The diagnostic yield of Qalb and CSF-TP levels in GBS patients were highly correlated, but lower when using age-adjusted reference ranges and at earlier timepoints.

JOURNAL OF NEUROLOGY (2021)

添加到收藏夹

Article Clinical Neurology

Guillain-Barre Syndrome Variant Occurring after SARS-CoV-2 Vaccination

Christopher Martin Allen et al.

Summary: Vigilance is needed for rare cases of Guillain-Barre syndrome following vaccination, and robust surveillance programs are recommended to assess causality.

ANNALS OF NEUROLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination

Yew Li Dang et al.

Summary: This case highlights the importance of recognizing rare neurological complications post-vaccination, particularly GBS and MFS syndrome overlap, which have potential implications for patient counselling and monitoring.

BMJ CASE REPORTS (2021)

添加到收藏夹

Article Medicine, General & Internal

Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1

Shreena Umit Patel et al.

Summary: This case report highlights a rare occurrence of Guillain-Barre syndrome following COVID-19 vaccination. The patient received treatment with intravenous immunoglobulin and did not require respiratory support, and is currently on the path to recovery with multidisciplinary team follow-up.

BMJ CASE REPORTS (2021)

添加到收藏夹

Article Clinical Neurology